Last reviewed · How we verify

NCT06561295

Optimal Timing for Spontaneous Breathing Trials

Recruiting now NA Last updated 30 September 2025
What this trial tests

NA trial testing Later Morning Timing of Spontaneous Breathing Trials in Respiration, Artificial in 348 participants. Currently enrolling.

Timeline
17 September 2024
Primary endpoint
30 June 2026
30 December 2026

Quick facts

Lead sponsorRush University Medical Center
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment348
Start date17 September 2024
Primary completion30 June 2026
Estimated completion30 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Rush University Medical Center

Who can join

21 and older, any sex, with Respiration, Artificial or Weaning. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to explore how the timing of Spontaneous Breathing Trials (SBTs) affects recovery in adult patients who are on mechanical ventilation in the ICU. SBTs are tests used to determine if a patient is ready to breathe on their own without the help of a ventilator. The study will compare two different timing strategies for these trials: one group of patients will have the test early in the morning, while the other group will have it later in the morning. By observing the outcomes, such as how long patients need to stay on the ventilator, the study hopes to find the best time to perform these trials to help patients recover more quickly and safely.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Respiration, Artificial

Currently open trials in the same condition.

Other Rush University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06561295.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing